Literature DB >> 29380244

Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture.

Mehdi Najar1, Mohammad Fayyad-Kazan2, Nathalie Meuleman1,3, Dominique Bron1,3, Hussein Fayyad-Kazan4, Laurence Lagneaux1.   

Abstract

Due to their easier isolation, multilineage potential, and immunomodulatory capacity, Wharton's Jelly-derived mesenchymal stromal cells (WJ-MSCs) exhibit promising efficacy in the field of regenerative medicine and immunotherapy. Characterization of WJ-MSCs-natural killer (NK) cells crosstalk is required for ameliorating the medicinal value of WJ-MSCs. Here, we revealed that the outcome of WJ-MSCs-NK cells crosstalk varied according to the type of cytokines (IL-2, IL-12, IL-15 and IL-21) utilized to activate NK cells. Differently activated NK cells exerted distinct cytotoxicities against WJ-MSCs causing their probable death. Cell surface ligands (CD112, CD155, ULPB-3) and receptors (LAIR, CD226, CD314, CD335, CD336 and CD337) governing the interaction between NK cells and their targets, exhibited altered expression profiles following the co-culture with WJ-MSCs. Although partly inhibited NK cell proliferation, WJ-MSCs enhanced activated NK-cell-mediated secretion of IFN-γ and TNF-α. Moreover, WJ-MSCs reinforced NK cells' degranulation as well as secretion of perforin and granzymes. On the other hand, WJ-MSCs displayed only slight increase in ROS generation but significant decrease in A1 and C1 serpins expression following co-culture with activated NK cells. Altogether, our results highlight that WJ-MSCs-NK cells interaction may affect both cell type features and, therefore, their therapeutic properties.

Entities:  

Keywords:  Cell crosstalk; Immunomodulation; Natural killer cells; Wharton’s Jelly mesenchymal stromal cells

Mesh:

Substances:

Year:  2018        PMID: 29380244     DOI: 10.1007/s11010-018-3297-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  65 in total

1.  Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.

Authors:  Ida Rasmusson; Olle Ringdén; Berit Sundberg; Katarina Le Blanc
Journal:  Transplantation       Date:  2003-10-27       Impact factor: 4.939

2.  Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function.

Authors:  Heba Abdelrazik; Grazia M Spaggiari; Laura Chiossone; Lorenzo Moretta
Journal:  Eur J Immunol       Date:  2011-10-18       Impact factor: 5.532

Review 3.  Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.

Authors:  Michael R Verneris
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

4.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

5.  Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.

Authors:  Belén Blanco; María Del Carmen Herrero-Sánchez; Concepción Rodríguez-Serrano; María Lourdes García-Martínez; Juan F Blanco; Sandra Muntión; Mariano García-Arranz; Fermín Sánchez-Guijo; Consuelo Del Cañizo
Journal:  Eur J Haematol       Date:  2016-06-01       Impact factor: 2.997

6.  Human decidua mesenchymal stem cells regulate decidual natural killer cell function via interactions between collagen and leukocyte‑associated immunoglobulin‑like receptor 1.

Authors:  Qiang Fu; Xuejing Man; Min Yu; Yongli Chu; Xiying Luan; Hailan Piao; Jiangnan Xue; Changzhu Jin
Journal:  Mol Med Rep       Date:  2017-07-05       Impact factor: 2.952

Review 7.  The structural basis of ligand recognition by natural killer cell receptors.

Authors:  M Gordon Joyce; Peter D Sun
Journal:  J Biomed Biotechnol       Date:  2011-05-18

8.  Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity.

Authors:  Debanjana Chatterjee; Nicole Marquardt; Dejene Milkessa Tufa; Guillaume Beauclair; Hui Zhi Low; Tim Hatlapatka; Ralf Hass; Cornelia Kasper; Constantin von Kaisenberg; Reinhold Ernst Schmidt; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2014-09-30       Impact factor: 5.712

9.  Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.

Authors:  Samantha F H de Witte; Ana M Merino; Marcella Franquesa; Tanja Strini; Johanna A A van Zoggel; Sander S Korevaar; Franka Luk; Madhu Gargesha; Lisa O'Flynn; Debashish Roy; Steve J Elliman; Philip N Newsome; Carla C Baan; Martin J Hoogduijn
Journal:  Stem Cell Res Ther       Date:  2017-06-08       Impact factor: 6.832

10.  Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.

Authors:  Rongtao Cui; Heike Rekasi; Monika Hepner-Schefczyk; Kai Fessmann; Robert M Petri; Kirsten Bruderek; Sven Brandau; Marcus Jäger; Stefanie B Flohé
Journal:  Stem Cell Res Ther       Date:  2016-07-07       Impact factor: 6.832

View more
  4 in total

Review 1.  Mesenchymal Stem Cell-Immune Cell Interaction and Related Modulations for Bone Tissue Engineering.

Authors:  Renxin Chen; Zhuowen Hao; Yi Wang; Hongzhen Zhu; Yingkun Hu; Tianhong Chen; Peng Zhang; Jingfeng Li
Journal:  Stem Cells Int       Date:  2022-02-01       Impact factor: 5.443

Review 2.  Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications.

Authors:  Batol Abbasi; Karim Shamsasenjan; Majid Ahmadi; Seyedeh Ameneh Beheshti; Mahshid Saleh
Journal:  Stem Cell Res Ther       Date:  2022-03-07       Impact factor: 6.832

Review 3.  Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection.

Authors:  Panagiotis Mallis; Efstathios Michalopoulos; Theofanis Chatzistamatiou; Catherine Stavropoulos-Giokas
Journal:  World J Stem Cells       Date:  2020-08-26       Impact factor: 5.326

4.  Extracellular Matrix From Decellularized Wharton's Jelly Improves the Behavior of Cells From Degenerated Intervertebral Disc.

Authors:  Letizia Penolazzi; Michela Pozzobon; Leticia Scussel Bergamin; Stefania D'Agostino; Riccardo Francescato; Gloria Bonaccorsi; Pasquale De Bonis; Michele Cavallo; Elisabetta Lambertini; Roberta Piva
Journal:  Front Bioeng Biotechnol       Date:  2020-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.